Volume 22, Issue 2 pp. 169-178
Original Article

The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report

K. Harrold BSc (Hons)

K. Harrold BSc (Hons)

Chemotherapy & IV Access Advanced Nurse Practitioner

Chemotherapy Unit, Mount Vernon Cancer Centre, Northwood, Middlesex, UK

Search for more papers by this author
D. Gould BSc MPhil PhD RGN RNT

D. Gould BSc MPhil PhD RGN RNT

Professor

Applied Health, City University, London, UK

Search for more papers by this author
N. Drey BA MBA PhD DFPH

N. Drey BA MBA PhD DFPH

Senior Lecturer

Health Services Research, City University, London, UK

Search for more papers by this author
First published: 16 January 2013
Citations: 16
Correspondence address: Karen Harrold, Mount Vernon Cancer Centre, Chemotherapy Unit, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK (e-mail: [email protected]).
Disclosures: Funding has been obtained from ‘The Florence Nightingale Foundation’ and ‘The General Council for England and Wales Trust’ in order to support Karen Harrold in this work as part of a PhD research study. Karen Harrold has also sat on an advisory board for Spe-Pharma and participated in a National Extravasation Information Service (NEXIS) round table advisory group sponsored by Spe-Pharma.

The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasationa historical case series report

This report presents the results from a historical case series of cytotoxic drug extravasations managed by saline washout; its purpose is to assess the efficacy of the procedure based on patient outcome. Eighty-nine patients were identified as having experienced a vesicant or exfoliant extravasation from incident reports filed over a 10-year period, from 1 April 2001 to 31 March 2011. Outcome was measured against the need for further surgical treatment being required. Of the 89 cases assessed for efficacy of saline washout one patient experienced a wound infection, which was treated effectively with oral antibiotics. There were no other complications reported and no patients required further treatment with surgical debridement. The majority of patients had no deferral of treatment as chemotherapy could be continued in their unaffected arm immediately following saline washout procedure. For patients where cannulation in their opposite arm for continuation of treatment was not advisable chemotherapy was delayed between 3 and 7 days. Hospitalisation as a result of the extravasation or subsequent treatment was not required in any of the 89 cases. Results indicate that saline washout technique is a safe and effective management strategy for the treatment of both vesicant and exfoliant chemotherapy extravasation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.